112 related articles for article (PubMed ID: 17487852)
1. The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
Rapkiewicz A; Espina V; Zujewski JA; Lebowitz PF; Filie A; Wulfkuhle J; Camphausen K; Petricoin EF; Liotta LA; Abati A
Cancer; 2007 Jun; 111(3):173-84. PubMed ID: 17487852
[TBL] [Abstract][Full Text] [Related]
2. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
3. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ; Lovell MO; Izbicka E
Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
[TBL] [Abstract][Full Text] [Related]
4. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of a positive axillary lymph node fine-needle aspirate in patients with invasive breast carcinoma.
Chang MC; Escallon JM; Colgan TJ
Cancer Cytopathol; 2014 Feb; 122(2):138-44. PubMed ID: 24106096
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.
Garuti A; Rocco I; Cirmena G; Chiaramondia M; Baccini P; Calabrese M; Palermo C; Friedman D; Zoppoli G; Ballestrero A
Gynecol Oncol; 2014 Feb; 132(2):389-96. PubMed ID: 24269902
[TBL] [Abstract][Full Text] [Related]
7. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens].
Zhang Z; Zhao L; Guo H; Guo L; Ling Y; Xu X; Zhao H; Pan Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):183-7. PubMed ID: 24785277
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
Jing X; Wey E; Michael CW
Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
[TBL] [Abstract][Full Text] [Related]
9. Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women.
Ballo MS; Sneige N
Cancer; 1996 Aug; 78(4):773-7. PubMed ID: 8756371
[TBL] [Abstract][Full Text] [Related]
10. A new specially designed needle significantly increases sample yield during fine needle aspiration of breast lesions.
Wiksell H; Ekstrand V; Wadström C; Auer G
Phys Med; 2009 Mar; 25(1):47-50. PubMed ID: 18313964
[TBL] [Abstract][Full Text] [Related]
11. Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.
Ernst LM; Rimm DL
Cancer; 2002 Oct; 96(5):275-9. PubMed ID: 12378594
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
Wulfkuhle JD; Speer R; Pierobon M; Laird J; Espina V; Deng J; Mammano E; Yang SX; Swain SM; Nitti D; Esserman LJ; Belluco C; Liotta LA; Petricoin EF
J Proteome Res; 2008 Apr; 7(4):1508-17. PubMed ID: 18257519
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of axillary lymph node fine-needle aspiration in the management of carcinoma of the breast.
Chang MC; Crystal P; Colgan TJ
Cancer Cytopathol; 2011 Oct; 119(5):328-34. PubMed ID: 21433002
[TBL] [Abstract][Full Text] [Related]
14. An analysis of fine needle aspiration versus core needle biopsy in clinically palpable breast lesions: a report on the predictive values and a cost comparison.
Nagar S; Iacco A; Riggs T; Kestenberg W; Keidan R
Am J Surg; 2012 Aug; 204(2):193-8. PubMed ID: 22464444
[TBL] [Abstract][Full Text] [Related]
15. Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.
Bu D; Lewis CM; Sarode V; Chen M; Ma X; Lazorwitz AM; Rao R; Leitch M; Moldrem A; Andrews V; Gazdar A; Euhus D
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2212-21. PubMed ID: 24089458
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of fine needle non-aspiration cytology versus fine needle aspiration cytology in breast masses.
Baksh S; Masih K; Singh S; Das S
Indian J Pathol Microbiol; 2004 Jul; 47(3):319-21. PubMed ID: 16295414
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
18. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.
Wong V; Wang DY; Warren K; Kulkarni S; Boerner S; Done SJ; Leong WL
BMC Cancer; 2008 Sep; 8():277. PubMed ID: 18826606
[TBL] [Abstract][Full Text] [Related]
19. [Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].
Lee JW; Noh WC; Kim MS; Kim HA; Chang YH; Hong YJ; Hong SI; Lee JK
Korean J Lab Med; 2008 Oct; 28(5):392-9. PubMed ID: 18971621
[TBL] [Abstract][Full Text] [Related]
20. Liquid-based cytology in fine-needle aspiration of breast lesions: a review.
Gerhard R; Schmitt FC
Acta Cytol; 2014; 58(6):533-42. PubMed ID: 25115652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
